🇺🇸 FDA

Company profile · Sponsor

Milestone

Milestone Pharmaceuticals

MIST · NYSE pharma MONTREAL, A8, USA
Pipeline
8
Drugs
5
Patents
8

Quick answer

Milestone (MIST) is a pharma company. headquartered in MONTREAL, A8, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 5 drugs, and 8 patents to this profile..

Company facts

Ticker MIST
Exchange NYSE
Company type pharma
Headquarters MONTREAL, A8, USA
SEC CIK 0001408443

Pipeline (8)

Search pipeline →

  1. Etripamil

    Milestone

    Paroxysmal Supraventricular Tachycardia

    phase 3 small molecule terminated

    1 trial

  2. Etripamil NS

    Milestone

    Paroxysmal Supraventricular Tachycardia

    phase 3 small molecule active

    2 trials

  3. Etripamil NS 70 mg

    Milestone

    Paroxysmal Supraventricular Tachycardia

    phase 3 small molecule completed

    2 trials

  4. Etripamil NS 70 mg

    Milestone

    Tachycardia, Supraventricular

    phase 3 small molecule completed

    1 trial

  5. Placebo

    Milestone

    Atrial Fibrillation

    phase 3 small molecule active

    1 trial

  6. Etripamil

    Milestone

    Paroxysmal Supraventricular Tachycardia (PSVT)

    phase 2 small molecule completed

    1 trial

  7. Etripamil

    Milestone

    Atrial Fibrillation

    phase 2 small molecule completed

    1 trial

  8. Etripamil Nasal Spray 70mg

    Milestone

    Healthy Chinese Subjects

    phase 1 small molecule completed

    1 trial

Drugs (5)

Search drugs →

  1. etripamil

    CARDAMYST

    NASAL approved

  2. mannitol

    BRONCHITOL

    IRRIGATION approved

    R05CB16

  3. procaine hydrochloride

    PROCAINE HYDROCHLORIDE

    INJECTION approved

  4. sodium chloride

    SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

    IRRIGATION approved

  5. sterile water for irrigation

    STERILE WATER IN PLASTIC CONTAINER

    IRRIGATION approved

Patents (8)

Search patents →

  1. US 12257224

    Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10632255

    Drug infusion device

    Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10308609

    Bicyclic compounds

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10251851

    Bicyclic analgesic compounds

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10117848

    Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10010522

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10010524

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10010523

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Milestone?

Milestone (MIST) is a pharma company. headquartered in MONTREAL, A8, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 5 drugs, and 8 patents to this profile..

What pipeline programs does Milestone sponsor?

We track 8 ClinicalTrials.gov-linked programs for Milestone, including Etripamil and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Milestone company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.